APA

Soria J., Fülöp A., Maciel C., Fischer J. R., Girotto G., Lago S., Smit E., Ostoros G., Eberhardt W. E. E., Lishkovska P., Lovick S., Mariani G., McKeown A., Kilgour E., Smith P., Bowen K., Kohlmann A., Carlile D. J. & Jänne P. A. (20180502). SELECT-2: a phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced or metastatic non-small-cell lung cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Soria J-C, Fülöp A, Maciel C, Fischer J R, Girotto G, Lago S, Smit E, Ostoros G, Eberhardt W E E, Lishkovska P, Lovick S, Mariani G, McKeown A, Kilgour E, Smith P, Bowen K, Kohlmann A, Carlile D J and Jänne P A. 20180502. SELECT-2: a phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced or metastatic non-small-cell lung cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Soria J., Fülöp A., Maciel C., Fischer J. R., Girotto G., Lago S., Smit E., Ostoros G., Eberhardt W. E. E., Lishkovska P., Lovick S., Mariani G., McKeown A., Kilgour E., Smith P., Bowen K., Kohlmann A., Carlile D. J. and Jänne P. A. (20180502). SELECT-2: a phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced or metastatic non-small-cell lung cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Soria J-C, Fülöp A, Maciel C, Fischer J R, Girotto G, Lago S, Smit E, Ostoros G, Eberhardt W E E, Lishkovska P, Lovick S, Mariani G, McKeown A, Kilgour E, Smith P, Bowen K, Kohlmann A, Carlile D J and Jänne P A. SELECT-2: a phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced or metastatic non-small-cell lung cancer. : Annals of oncology : official journal of the European Society for Medical Oncology. 20180502.